StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

ARQT — Arcutis Biotherapeutics, Inc.

EXPENSIVE (MOS -195.5%) · Quality 71/100

Price
25.38
Intrinsic value
8.59
Margin of safety
-195.5%
Implied growth (reverse DCF)
+30.7%
model assumes +16.0%
Value Score
16.8
Quality
71
Psychology
5.6
Discovery
96.8
price/volume attention only
Moat score
33
erosion: none

Value Score: bottom 26% of Russell 3000 · Quality: top 14%

Open the interactive Deep Dive for ARQT →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ARQT - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ARQT undervalued?

As of 2026-09-19, ARQT trades at 25.38 against a computed intrinsic value of 8.59 (-195.5% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Arcutis Biotherapeutics, Inc.'s Value Score?

Arcutis Biotherapeutics, Inc.'s Value Score is 16.8 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.